Bellevue Group Ag Glaukos Corp Transaction History
Bellevue Group Ag
- $5.98 Billion
- Q2 2024
A detailed history of Bellevue Group Ag transactions in Glaukos Corp stock. As of the latest transaction made, Bellevue Group Ag holds 55,926 shares of GKOS stock, worth $7.17 Million. This represents 0.11% of its overall portfolio holdings.
Number of Shares
55,926
Previous 55,926
-0.0%
Holding current value
$7.17 Million
Previous $5.27 Million
25.51%
% of portfolio
0.11%
Previous 0.08%
Shares
14 transactions
Others Institutions Holding GKOS
# of Institutions
303Shares Held
47MCall Options Held
75.3KPut Options Held
157K-
Black Rock Inc. New York, NY8.04MShares$1.03 Billion0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.45MShares$700 Million0.01% of portfolio
-
Brown Capital Management LLC Baltimore, MD1.9MShares$243 Million4.61% of portfolio
-
State Street Corp Boston, MA1.86MShares$238 Million0.01% of portfolio
-
Invesco Ltd. Atlanta, GA1.61MShares$207 Million0.04% of portfolio
About GLAUKOS Corp
- Ticker GKOS
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 47,596,900
- Market Cap $6.11B
- Description
- Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...